Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration Resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration Resistant Prostate Cancer trial results

Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

NCT02952534

Conditions
Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related, Metastatic Castration Resistant Prostate Cancer
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinc Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Alliance Research Centers Laguna Hills, California, United States
View all 149 locations
View Trial Details
Completed

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

NCT02655822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 20 locations
View Trial Details
Completed

Optimizing Abiraterone Therapy

NCT02426333

Conditions
Metastatic Castration Resistant Prostate Cancer
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • Canisius Wilhelmina Ziekenhuis Nijmegen, Netherlands
  • Radboud UMC Nijmegen, Netherlands
View Trial Details
Completed

Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer

NCT04056754

Conditions
Metastatic Castration Resistant Prostate Cancer
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun-Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View all 16 locations
View Trial Details

Related conditions